MedPath
FDA Approval

TELMISARTAN

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Chartwell RX, LLC.
DUNS: 079394054
Effective Date
March 10, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Telmisartan(20 mg in 1 1)

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TELMISARTAN

Product Details

NDC Product Code
62135-535
Application Number
ANDA078710
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 10, 2023
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
MEGLUMINEInactive
Code: 6HG8UB2MUYClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
Code: U5SYW473RQClass: ACTIBQuantity: 20 mg in 1 1

TELMISARTAN

Product Details

NDC Product Code
62135-537
Application Number
ANDA078710
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 10, 2023
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MEGLUMINEInactive
Code: 6HG8UB2MUYClass: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
Code: U5SYW473RQClass: ACTIBQuantity: 80 mg in 1 1

TELMISARTAN

Product Details

NDC Product Code
62135-536
Application Number
ANDA078710
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 10, 2023
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
Code: U5SYW473RQClass: ACTIBQuantity: 40 mg in 1 1
MEGLUMINEInactive
Code: 6HG8UB2MUYClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath